Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Health Times Cambodia.

Ceramic Tile Market To Reach USD 809.22 Billion by 2032, Expected to Grow at 7.1% Through 2025 To 2032
Ceramic Tile Market size was valued at US$ 467.47 Bn. in 2024 and is expected to grow at 7.1% through 2025 to 2032, reaching nearly US$ 809.22 Bn. by 2032 WILMINGTON, DE, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- Stellar Market Research...

Indonesia’s Top Employers Forge the Future of Work: HR Asia Honors 80 Companies in Talent Innovation
JAKARTA, Indonesia, July 01, 2025 (GLOBE NEWSWIRE) -- HR Asia Best Companies to Work for in Asia, owned by Business Media International, proudly honours 80 organizations that exemplify excellence in human capital strategy and workplace culture....

Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to...

Long Beach Councilwoman Suely Saro Elected Board Chair of the Alameda Corridor Transportation Authority
LONG BEACH,, CA, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Long Beach Councilwoman Suely Saro has been elected Chair of the Governing Board of the Alameda Corridor Transportation Authority (ACTA) for the 2025-2026 term, her second time...

Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...

Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition...

Pallets Market to Grow from $57.4 Billion in 2010 to $130.5 Billion by 2032, with a CAGR of 4.1% from 2023-2032
Global Pallets Market Research, 2032 WILMINGTON, DE, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- The global 𝐩𝐚𝐥𝐥𝐞𝐭𝐬 𝐦𝐚𝐫𝐤𝐞𝐭, valued at $57.4 billion in 2010, is projected to reach $130.5 billion by 2032, registering a compound annual...

NewGenIVF Announces Reverse Stock Split
BANGKOK, May 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today...

SUN Bucks - Family Food Program
Keep Your Kids Nourished This Summer with SUN Bucks – What Boston Families Need to Know To support families with children put food on the table while school is out, the Massachusetts Department of Transitional Assistance (DTA) is offering SUN...

Sean Riley of Central Michigan University awarded the 2025 CAHME/Tim Campbell Scholarship for Selfless Service to Others
SPRING HOUSE , PA, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- Sean Riley a MHA Candidate at Central Michigan University, has been named the 2025 CAHME/Tim Campbell Scholarship recipient for Selfless Service to Others and the Community. He...

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...

NewGen Filed 2024 Annual Report on Form 20-F
BANGKOK, April 22, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today...

ICRC president: Civilians will pay the price if global commitment to ban landmines allowed to fracture
The global consensus that once made anti-personnel mines a symbol of inhumanity is starting to fracture. After decades of progress, we are witnessing a dangerous shift: states that once championed disarmament are now considering withdrawing from...

Alvotech Reports Record Results for 2024 and Provides Business Update
Total Revenues in 2024 reached $492 million, representing a 427% increase over prior year Product Revenues in 2024 reached $273 million, representing a 462% increase over prior year Adjusted EBITDA in 2024 was $108.3 million compared to negative...

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...

Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
HYDERABAD, India and REYKJAVIK, Iceland, March 18, 2025 (GLOBE NEWSWIRE) -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Alvotech...

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI SELARSDI is...

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI SELARSDI is...